HElmet therapy Assessment in infants with Deformed Skulls (HEADS): protocol for a randomised controlled trial

Renske M van Wijk, Magda M Boere-Boonekamp, Catharina G M Groothuis-Oudshoorn, Leo A van Vlimmeren, Maarten J IJzerman, Renske M van Wijk, Magda M Boere-Boonekamp, Catharina G M Groothuis-Oudshoorn, Leo A van Vlimmeren, Maarten J IJzerman

Abstract

Background: In The Netherlands, helmet therapy is a commonly used treatment in infants with skull deformation (deformational plagiocephaly or deformational brachycephaly). However, evidence of the effectiveness of this treatment remains lacking. The HEADS study (HElmet therapy Assessment in Deformed Skulls) aims to determine the effects and costs of helmet therapy compared to no helmet therapy in infants with moderate to severe skull deformation.

Methods/design: Pragmatic randomised controlled trial (RCT) nested in a cohort study. The cohort study included infants with a positional preference and/or skull deformation at two to four months (first assessment). At 5 months of age, all children were assessed again and infants meeting the criteria for helmet therapy were asked to participate in the RCT. Participants were randomly allocated to either helmet therapy or no helmet therapy. Parents of eligible infants that do not agree with enrolment in the RCT were invited to stay enrolled for follow up in a non-randomisedrandomised controlled trial (nRCT); they were then free to make the decision to start helmet therapy or not. Follow-up assessments took place at 8, 12 and 24 months of age. The main outcome will be head shape at 24 months that is measured using plagiocephalometry. Secondary outcomes will be satisfaction of parents and professionals with the appearance of the child, parental concerns about the future, anxiety level and satisfaction with the treatment, motor development and quality of life of the infant. Finally, compliance and costs will also be determined.

Discussion: HEADS will be the first study presenting data from an RCT on the effectiveness of helmet therapy. Outcomes will be important for affected children and their parents, health care professionals and future treatment policies. Our findings are likely to influence the reimbursement policies of health insurance companies.Besides these health outcomes, we will be able to address several methodological questions, e.g. do participants in an RCT represent the eligible target population and do outcomes of the RCT differ from outcomes found in the nRCT?

Trial registration: ISRCTN18473161.

Figures

Figure 1
Figure 1
Flow chart of participants in HEADS. Provisional data.

References

    1. Boere-Boonekamp MM, van der Linden-Kuiper LT. Positional preference: prevalence in infants and follow-up after two years. Pediatrics. 2001;107:339–343. doi: 10.1542/peds.107.2.339.
    1. Mulliken JB, Vander Woude DL, Hansen M, LaBrie RA, Scott RM. Analysis of posterior plagiocephaly: deformational versus synostotic. Plast Reconstr Surg. 1999;103:371–380. doi: 10.1097/00006534-199902000-00003.
    1. Argenta L, David L, Thompson J. Clinical classification of positional plagiocephaly. J Craniofac Surg. 2004;15:368–372. doi: 10.1097/00001665-200405000-00004.
    1. Clarren SK. Plagiocephaly and torticollis: etiology, natural history, and helmet treatment. J Pediatr. 1981;98:92–95. doi: 10.1016/S0022-3476(81)80549-5.
    1. Collett B, Breiger D, King D, Cunningham M, Speltz M. Neurodevelopmental implications of "deformational" plagiocephaly. J Dev Behav Pediatr. 2005;26:379–389. doi: 10.1097/00004703-200510000-00008.
    1. Balan P, Kushnerenko E, Sahlin P, Huotilainen M, Naatanen R, Hukki J. Auditory ERPs reveal brain dysfunction in infants with plagiocephaly. J Craniofac Surg. 2002;13:520–525. doi: 10.1097/00001665-200207000-00008. discussion 526.
    1. Miller RI, Clarren SK. Long-term developmental outcomes in patients with deformational plagiocephaly. Pediatrics. 2000;105:E26. doi: 10.1542/peds.105.2.e26.
    1. Hutchison BL, Hutchison LA, Thompson JM, Mitchell EA. Plagiocephaly and brachycephaly in the first two years of life: a prospective cohort study. Pediatrics. 2004;114:970–980. doi: 10.1542/peds.2003-0668-F.
    1. Hutchison BL, Stewart AW, Mitchell EA. Deformational plagiocephaly: a follow-up of head shape, parental concern and neurodevelopment at ages 3 and 4 years. Arch Dis Child. 2010;96:85–90.
    1. van Vlimmeren LA, van der Graaf Y, Boere-Boonekamp MM, L'Hoir MP, Helders PJ, Engelbert RH. Effect of pediatric physical therapy on deformational plagiocephaly in children with positional preference: a randomised controlled trial. Arch Pediatr Adolesc Med. 2008;162:712–718. doi: 10.1001/archpedi.162.8.712.
    1. Bialocerkowski AE, Vladusic SL, Wei Ng C. Prevalence, risk factors, and natural history of positional plagiocephaly: a systematic review. Dev Med Child Neurol. 2008;50:577–586. doi: 10.1111/j.1469-8749.2008.03029.x.
    1. Hutchison BL, Stewart AW, Mitchell EA. Characteristics, head shape measurements and developmental delay in 287 consecutive infants attending a plagiocephaly clinic. Acta Paediatr. 2009;98:1494–1499. doi: 10.1111/j.1651-2227.2009.01356.x.
    1. Hutchison BL, Thompson JM, Mitchell EA. Determinants of nonsynostotic plagiocephaly: a case–control study. Pediatrics. 2003;112:e316. doi: 10.1542/peds.112.4.e316.
    1. van Vlimmeren LA, van der Graaf Y, Boere-Boonekamp MM, L'Hoir MP, Helders PJ, Engelbert RH. Risk factors for deformational plagiocephaly at birth and at 7 weeks of age: a prospective cohort study. Pediatrics. 2007;119:e408–e418. doi: 10.1542/peds.2006-2012.
    1. McKinney CM, Cunningham ML, Holt VL, Leroux B, Starr JR. A case–control study of infant, maternal and perinatal characteristics associated with deformational plagiocephaly. Paediatr Perinat Epidemiol. 2009;23:332–345. doi: 10.1111/j.1365-3016.2009.01038.x.
    1. Michels AC, van den Elzen ME, Vles JS, van der Hulst RR. Prevalence of positional plagiocephaly and excessive folic acid intake during pregnancy. Cleft Palate Craniofac J. 2012;49:1–4. doi: 10.1597/09-096.
    1. Weernink MGM, van Wijk RM, Groothuis-Oudshoorn CGM, Van Vlimmeren LA, Lanting CI, Boere-Boonekamp MM. De relatie tussen vitamine-D-inname en schedeldeformatie bij zuigelingen [abstract] Tijdschrift voor Jeugdgezondheidszorg. 2011;4:1.
    1. Hutchison BL, Stewart AW, De Chalain TB, Mitchell EA. A randomised controlled trial of positioning treatments in infants with positional head shape deformities. Acta Paediatr. 2010;99:1556–1560. doi: 10.1111/j.1651-2227.2010.01872.x.
    1. Pollack IF, Losken HW, Fasick P. Diagnosis and management of posterior plagiocephaly. Pediatrics. 1997;99:180–185. doi: 10.1542/peds.99.2.180.
    1. Lipira AB, Gordon S, Darvann TA, Hermann NV, Van Pelt AE, Naidoo SD, Govier D, Kane AA. Helmet versus active repositioning for plagiocephaly: a three-dimensional analysis. Pediatrics. 2010;126:e936–e945. doi: 10.1542/peds.2009-1249.
    1. Littlefield TR. Cranial remodeling devices: treatment of deformational plagiocephaly and postsurgical applications. Semin Pediatr Neurol. 2004;11:268–277. doi: 10.1016/j.spen.2004.10.004.
    1. Loveday BP, de Chalain TB. Active counterpositioning or orthotic device to treat positional plagiocephaly? J Craniofac Surg. 2001;12:308–313. doi: 10.1097/00001665-200107000-00003.
    1. Vles JS, Colla C, Weber JW, Beuls E, Wilmink J, Kingma H. Helmet versus nonhelmet treatment in nonsynostotic positional posterior plagiocephaly. J Craniofac Surg. 2000;11:572–574. doi: 10.1097/00001665-200011060-00010.
    1. Lee A, Van Pelt AE, Kane AA, Pilgram TK, Govier DP, Woo AS, Smyth MD. Comparison of perceptions and treatment practices between neurosurgeons and plastic surgeons for infants with deformational plagiocephaly. Journal of Neurosurgery: Pediatrics. 2010;5:368–374. doi: 10.3171/2009.11.PEDS0983.
    1. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62:464–475. doi: 10.1016/j.jclinepi.2008.12.011.
    1. Macpherson H. Pragmatic clinical trials. Complement Ther Med. 2004;12:136–140. doi: 10.1016/j.ctim.2004.07.043.
    1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637–648. doi: 10.1016/0021-9681(67)90041-0.
    1. Fransen GAJ, van Marrewijk CJ, Mujakovic S, Muris JWM, Laheij RJF, Numans ME, de Wit NJ, Samsom M, Jansen JBMJ, Knottnerus JA. Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study. BMC Med Res Methodol. 2007;7:16.
    1. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–1632. doi: 10.1001/jama.290.12.1624.
    1. Relton C, Torgerson D, O'Cathain A, Nicholl J. Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ. 2010;340:c1066–c1066. doi: 10.1136/bmj.c1066.
    1. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S, Neal D, Hamdy F. Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ. 2002;325:766–770.
    1. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52:1143–1156. doi: 10.1016/S0895-4356(99)00141-9.
    1. Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess. 2005;9:1–152. iii-iv, ix-x.
    1. Bonell C, Oakley A, Hargreaves J, Strange V, Rees R. Assessment of generalisability in trials of health interventions: suggested framework and systematic review. BMJ. 2006;333:346–349. doi: 10.1136/bmj.333.7563.346.
    1. van Adrichem LNA, van Vlimmeren LA, Cadanova D, Helders PJM, Engelbert RHH, van Neck HJW, Koning AHJ. Validation of a simple method for measuring cranial deformities (Plagiocephalometry) J Craniofac Surg. 2008;19:15–21.
    1. van Vlimmeren LA, Takken T, van Adrichem LN, van der Graaf Y, Helders PJ, Engelbert RH. Plagiocephalometry: a non-invasive method to quantify asymmetry of the skull; a reliability study. Eur J Pediatr. 2006;165:149–157. doi: 10.1007/s00431-005-0011-1.
    1. Laurent Angulo MS, Brouwers-de Jong EA, Bijlsma-Schlösser JFM, Bulk-Bunschoten AMW, Pauwels JH, Steinbuch-Linstra I, editor. Ontwikkelingsonderzoek in de jeugdgezondheidszorg. Het Van Wiechenonderzoek – De Baecke-Fassaert Motoriektest. , Assen. Van Gorcum; 2005.
    1. Bayley N. Manual for the Bayley Scales of Infant and Toddler Development 3rd edition. Psychological Corp, San Antonio, TX; 2006.
    1. van der Ploeg HM, Defares PB, Spielberger CD. Handleiding bij de Zelf-Beoordelings Vragenlijst, ZBV: Een Nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Swets & Zeitlinger, Lisse; 1980.
    1. Raat H, Landgraf JM, Oostenbrink R, Moll HA, Essink-Bot M-L. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res. 2006;16:445–460.
    1. Van Buuren S, Groothuis-Oudshoorn CGM. mice: Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45:1–67.
    1. Haidich AB, Ioannidis JPA. Patterns of patient enrollment in randomised controlled trials. J Clin Epidemiol. 2001;54:877–883. doi: 10.1016/S0895-4356(01)00353-5.
    1. Petticrew M, Roberts H. Evidence, hierarchies, and typologies: horses for courses. J Epidemiol Community Health. 2003;57:527–529. doi: 10.1136/jech.57.7.527.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa